UK Biobank has been set up, and is funded, by the Wellcome Trust, the Medical Research Council, the Northwest Regional Development Agency, the Department of Health, and the Scottish Government. The medical research project is being run as a non-profit charity with initial funding of about £62 million. UK Biobank has its headquarters at the University of Manchester. Its Principal Investigator and Chief Executive is Professor Rory Collins, who is also British Heart Foundation (BHF) Professor of Medicine and Epidemiology at the University of Oxford. UK Biobank has the support of the National Health Service (NHS) and is working with 22 universities across Britain.












